TASSI, Renata Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.574
EU - Europa 634
AS - Asia 308
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 2.520
Nazione #
US - Stati Uniti d'America 1.560
PL - Polonia 249
CN - Cina 186
UA - Ucraina 127
DE - Germania 94
SG - Singapore 50
IT - Italia 49
FI - Finlandia 48
HK - Hong Kong 36
GB - Regno Unito 24
IE - Irlanda 19
TR - Turchia 18
CA - Canada 13
FR - Francia 11
SE - Svezia 8
VN - Vietnam 8
IN - India 4
EU - Europa 3
CZ - Repubblica Ceca 2
ID - Indonesia 2
LK - Sri Lanka 2
NL - Olanda 2
AZ - Azerbaigian 1
BR - Brasile 1
BY - Bielorussia 1
CR - Costa Rica 1
KZ - Kazakistan 1
Totale 2.520
Città #
Warsaw 248
Fairfield 230
Woodbridge 197
Ashburn 123
Houston 119
Seattle 115
Ann Arbor 97
Jacksonville 93
Dearborn 84
Wilmington 82
Cambridge 79
Chandler 68
New York 42
Princeton 38
Hong Kong 36
Singapore 34
Helsinki 32
Nanjing 32
Beijing 22
Dublin 19
Shanghai 18
Istanbul 17
Jinan 16
Shenyang 14
Toronto 13
Los Angeles 12
Nanchang 12
Kunming 10
San Diego 10
Changsha 8
Dong Ket 8
Hebei 8
Monmouth Junction 8
Jiaxing 7
Milan 7
Brescia 6
Des Moines 6
London 6
Tianjin 6
Hangzhou 5
Hefei 4
Leawood 4
Munich 4
Zhengzhou 4
Lancaster 3
Lanzhou 3
Ningbo 3
Taiyuan 3
Brno 2
Clifton 2
Colombo 2
Jakarta 2
Norwalk 2
Phoenix 2
San Francisco 2
Almaty 1
Amsterdam 1
Baku 1
Baotou 1
Chengdu 1
Espoo 1
Falkenstein 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hounslow 1
Kilburn 1
Kocaeli 1
Minsk 1
Mumbai 1
New Bedfont 1
Newark 1
Orange 1
Padova 1
Redmond 1
Redwood City 1
San José 1
Segrate 1
Southwark 1
Stockholm 1
São Paulo 1
Taizhou 1
Verona 1
Washington 1
Wuhan 1
Xian 1
Zhangzhou 1
Totale 2.062
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 287
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 225
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 155
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 145
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 139
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 136
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 129
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 127
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 125
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 122
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 121
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 120
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 117
Mammaglobin B expression in human endometrial cancer 116
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 113
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 110
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 109
Claudin-7 expression in human epithelial ovarian cancer 88
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 86
Totale 2.570
Categoria #
all - tutte 10.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020545 0 0 0 0 53 124 109 85 57 70 10 37
2020/2021351 9 40 5 59 9 37 26 36 41 38 38 13
2021/2022211 33 38 4 2 0 10 14 13 4 37 20 36
2022/2023203 40 10 13 5 15 39 0 19 36 1 11 14
2023/2024237 14 8 28 26 13 55 14 9 37 10 4 19
2024/202561 8 7 1 45 0 0 0 0 0 0 0 0
Totale 2.570